Search results
Novavax (NVAX) Seeks FDA Nod for Updated COVID-19 Vaccine
Zacks via Yahoo Finance· 6 days agoNovavax (NVAX) seeks FDA???s approval to update its COVID-19 vaccine for the 2024-2025 fall season...
OpenAI And Color Health Develop AI-Driven Cancer Care Solutions: Report - Microsoft (NASDAQ:MSFT), ...
Benzinga· 6 days agoOpenAI and startup Color Health have developed an AI assistant, named 'copilot', to support...
Covid-19 Pharma Stars Continue Their Quest To Set New Standards In Cancer Treatment
Benzinga via Yahoo Finance· 5 days agoAstraZeneca PLC (NASDAQ: AZN) kicked off the week by receiving approval from the U.S. Food and Drug...
FDA’s Sarepta decision could represent ‘new way of thinking’ for agency - Boston Business Journal
The Business Journals· 3 hours agoThe U.S. Food and Drug Administration’s recent decision to expand approval for a Cambridge company’s controversial gene therapy could signal a changing approach to how the federal agency deals ...
Kansas sues Pfizer over ‘misleading statements’ about COVID vaccine
The Hill via AOL· 6 days agoThe state of Kansas filed a lawsuit Monday against pharmaceutical company Pfizer, alleging the...
Stonebridge Capital Management Inc. Boosts Stake in Walmart Inc. (NYSE:WMT)
ETF DAILY NEWS· 7 days agoStonebridge Capital Management Inc. raised its holdings in shares of Walmart Inc. (NYSE:WMT – Free...
Drug names: How companies and regulators come up with hundreds of new names every year
Quartz· 4 days agoEverything you need to know about the art and science of drug naming in five minutes or less,...
Gateway - Quartz
Quartz· 5 days agoA new study found that Novo Nordisk’s nearly $1,000 per month diabetes medication Ozempic can be produced for less than $5 a month. Novo Nordisk and Johnson & Johnson both announced billion-dollar ...
Gateway - Quartz
Quartz· 6 days agoHealthcare companies including Ro and Eli Lilly are introducing online supply trackers to help patients navigate ongoing GLP-1 drug shortages. Moderna says it is in talks ...
Pfizer Lingers Near 11-Year Low Despite Promising Cancer Drug Updates — Is It A Sell?
Investor's Business Daily· 3 days agoThe company also unveiled promising results in people age 18 to 59 years old with underlying...